Medicines run short in Iran under US sanctions - Financial Times
Medicines run short in Iran under US sanctions Financial Times
Related discussion groups
No group discusses this yet. Start a discussion group and attach this story.
More news about Iran
- Oil majors look beyond Middle East war in pursuit of region’s vast reservesWestern groups look to new investment opportunities despite the chaos and heightened risks caused by the conflict with Iran
- Oil companies are full speed ahead in the Middle EastWestern groups look to new investment opportunities despite the chaos and heightened risks caused by the conflict with Iran
- Trump says he is not keen on a deal with Iran as U.S. reportedly prepares for 'massive bombing'The U.S. president and his national security team have discussed possibly resuming large-scale U.S. military operations in the coming weeks, NBC News reported.
- Oil gains as Middle East hostilities stoke supply worriesPresident Donald Trump and his national security team have talked about possibly restarting large-scale U.S. military operations in Iran in the coming weeks, NBC News reported.
- US stocks slide as oil prices fluctuate over renewed Iran war fearsOil prices rose on fresh concerns about Middle East supplies, before falling on the possible release of more reserves.
- Worst-Performing Philippine Bonds Face Peso, Inflation RisksPhilippine bonds, the worst-performing in emerging markets since the Iran war began, are set for further losses as faster inflation, a sliding peso and softer auction demand weigh on sentiment, str...
- Military ordered to be ready for possible Iran strikes as Trump weighs timing - AxiosMilitary ordered to be ready for possible Iran strikes as Trump weighs timing Axios
- Explainer: The status of Iran's uranium enrichment programme - ReutersExplainer: The status of Iran's uranium enrichment programme Reuters